H.C. Wainwright Downgrades Cardiff Oncology (CRDF) to Neutral

June 1, 2026 6:41 AM

H.C. Wainwright analyst Raghuram Selvaraju downgraded Cardiff Oncology (NASDAQ: CRDF) from Buy to Neutral.The analyst comments "Nerviano announces termination of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found